...on drug pricing April 9. Invited PBMs include Cigna; CVS Health Corp. and CVS Caremark; Humana...
...said subcommittee Chair Rep. Diana DeGette (D-Colo.). Mary Romeo, Staff Writer Cigna Corp. CVS Health Corp. Eli Lilly and Co. Humana...

...drug pricing. Invited PBMs include Cigna Corp. (NYSE:CI); CVS Health Corp. (NYSE:CVS) and CVS Caremark; Humana...

...3. Ryu joined Geisinger in 2016 after serving as president of integrated care delivery at Humana...

...3. Ryu joined Geisinger in 2016 after serving as president of integrated care delivery at Humana...
...the University of Illinois Hospital & Health Sciences System. Mary Romeo Alphabet Inc. Cleveland Clinic Duke University Geisinger Health System Google Inc. Humana...

...not respond to inquiries. The five main insurers -- Aetna Inc. (NYSE:AET), Anthem Inc. (NYSE:ANTM), Humana...

...approval to Exondys 51 in September 2016 to treat DMD amendable to exon 51 skipping, Humana...
...NYSE:CI) and UnitedHealth Group Inc. (NYSE:UNH) each said they would cover the drug. In July, Humana...
...hours. Anthem Inc. (NYSE:ANTM), Indianapolis, Ind. Business: Cancer, Musculoskeletal Mary Romeo axicabtagene ciloleucel eteplirsen Exondys 51 KTE-C19 Yescarta Anthem Inc. Cigna Corp. Gilead Sciences Inc. Humana...

...approval to Exondys 51 in September 2016 to treat DMD amendable to exon 51 skipping, Humana...
...NYSE:CI) and UnitedHealth Group Inc. (NYSE:UNH) each said they would cover the drug. In July, Humana...
...$73.02 on Thursday, while Sarepta lost $0.27 to $52.17. Mary Romeo axicabtagene ciloleucel eteplirsen Exondys 51 Yescarta Anthem Inc. Cigna Corp. Gilead Sciences Inc. Humana...

...study evaluated 14,214 matched-pair patients receiving Eliquis or warfarin in an insurance claims database from Humana...
...Status: Postmarketing study data Milestone: NA Jaime De Leon apixaban BAY 59-7939 BMS-562247-01 dabigatran dabigatran etexilate mesylate Eliquis Pradax Pradaxa Prazaxa rivaroxaban Xarelto Bayer AG Boehringer Ingelheim GmbH Bristol-Myers Squibb Co. Humana...

...study evaluated 14,214 matched-pair patients receiving Eliquis or warfarin in an insurance claims database from Humana...

...meet the same criteria as those in Sarepta's trials (see BioCentury, Sept. 26, 2016) . Humana...